➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

AMPICILLIN SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ampicillin sodium and what is the scope of patent protection?

Ampicillin sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Aurobindo Pharma, Consolidated Pharm, Hanford Gc, Hospira Inc, Intl Medication, Istituto Bio Ita Spa, Lilly, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Watson Labs Inc, West-ward Pharms Int, Wyeth Ayerst, Bristol, Glaxosmithkline, Acs Dobfar, Astral, Pharm Assoc, and Pfizer, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy drug master file entries for ampicillin sodium. Fifteen suppliers are listed for this compound.

Recent Clinical Trials for AMPICILLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Haining Health-Coming Biotech Co., Ltd.Phase 2
DongGuk UniversityN/A
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all AMPICILLIN SODIUM clinical trials

Pharmacology for AMPICILLIN SODIUM
Medical Subject Heading (MeSH) Categories for AMPICILLIN SODIUM

US Patents and Regulatory Information for AMPICILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TOTACILLIN-N ampicillin sodium INJECTABLE;INJECTION 060677-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 201025-002 Apr 9, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 202864-002 Sep 4, 2015 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 090340-002 Sep 20, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.